We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Ethical Issues in Embryonic Stem Cell Research

Cynthia B. Cohen, PhD, JD
JAMA. 2001;285(11):1439-1440. doi:10.1001/jama.285.11.1439.
Text Size: A A A
Published online


To the Editor: In advocating the creation of embryos for stem cell research by means of somatic cell nuclear transfer, Dr Lanza and colleagues1 fail to recognize at least 2 major issues. First, they overlook the fact that human embryos must be created from the eggs of women. Producing eggs engenders increased risks for women. Hyperstimulation can lead to liver damage, kidney failure, or stroke, and ovulation-stimulating drugs have been associated with ovarian cancer, according to some studies.2 Although women might be willing to undergo such risks for the sake of having a child, it seems clear that either payment for eggs or coercion would have to be used to persuade women to produce eggs for stem cell research.3 As with kidneys, hearts, and certain other body parts, society is reluctant to allow human eggs to enter into the stream of commerce, fearing that this would compromise extraeconomic values of deep importance.4 Coercion as a means of promoting medical research has been strongly criticized.3 Thus, before considering embryonic stem cell research, procedures need to be developed to protect women's health and freedom from overbearing financial or other pressure.5


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.